Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry-Reference-Cited by-同舟云学术

Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry

Published:2012-04-25 Issue:9 Volume:51 Page:1618-1627
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Kvamme M. K.,Lie E.,Kvien T. K.,Kristiansen I. S.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/51/9/1618/17387721/kes074.pdf

Reference33 articles.

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

2. The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments

3. Cost Effectiveness of Tumour Necrosis Factor-?? Inhibitors as First-Line Agents in Rheumatoid Arthritis

4. Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration;Journal of Clinical Epidemiology;2024-02

2. Estimating the indirect costs associated with psoriasis;Kazan medical journal;2022-10-03

3. Work participation is unaffected in Belgian spondyloarthritis patients: data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT;Rheumatology;2022-09-13

4. Explaining the gap in the experience of depression among arthritis patients;Clinical Rheumatology;2022-01-07

5. Achievement of more stringent disease control is associated with reduced burden on workplace and household productivity: results from long-term certolizumab pegol treatment in patients with psoriatic arthritis;Therapeutic Advances in Musculoskeletal Disease;2022-01